Navigation Links
Screening For Prostate Cancer in men over 75 Questioned

The prostate specific antigen test is a convenient and relatively inexpensive way for early detection of prostate cancer. While efficacy of PSA is controversial in younger men, doctors say there is a general consensus that the test //should not be given to men over 75. Despite this, a new study finds many physicians are suggesting and doing a PSA test on older men.

The decision to not screen older men with a PSA test is because the life expectancy without the test is nearly identical to men who have the test and undergo therapy for prostate cancer. Researchers reviewed information from a previous study to see who was initiating the idea and if physicians are discussing the risks and benefits of a PSA screening with patients before testing.

The study included information from 7,889 men who participated in a previous survey. Researchers report 32.5 percent of the men 75 years or older said they had a PSA screening during the last year. Among the men who had the test, 88.4 percent say their doctor suggested the screening and 66.5 percent reported having a discussion about the advantages and disadvantages of the test with their doctor before the screening was done.

Researchers say it is somewhat surprising so many physicians would suggest a screening in an elderly patient and they also say that the Ultimate, decision regarding the appropriateness of PSA screening in elderly men and the allocation of health care resources will have to be made by patients, physicians, and society working together. They say information about how patients and physicians interpret medical data on the PSA screening is critical to understanding the risks and benefits of this test in elderly men.
'"/>




Page: 1

Related medicine news :

1. Screening device for ovarian cancer
2. Screening bypasses radical breast surgery
3. Screening of Lazy Eye
4. Screening Cost-Effective for Lung Cancer
5. Screening Newborns Questioned
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. The Effectiveness Of Screening Tests Questioned
8. Screening Test For Early Diagnosis Of Colorectal Cancer
9. The Importance Of Skin Cancer Screening
10. Ovarian Cancer Screening Questioned
11. Early Screening Required for Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: